Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

328 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Surveillance of systemic autoimmune rheumatic diseases using administrative data
Bernatsky S, et al. Rheumatol Int 2011. PMID 20665025
Cases of SARDs (systemic lupus erythematosus, scleroderma, primary Sjogren's, polymyositis/dermatomyositis) were ascertained from provincial physician billing and hospitalization data. ...The prevalence in older females approached or exceeded 1 in 100, which may reflect the high burden of primary Sjogren's syndrome in this group. ...
Cases of SARDs (systemic lupus erythematosus, scleroderma, primary Sjogren's, polymyositis/dermatomyositis) were ascertained from pro …
Medication non-adherence in women with fibromyalgia
Sewitch MJ, et al. Rheumatology (Oxford) 2004 - Clinical Trial. Among authors: Bernatsky S. PMID 14983107
Unintentional non-adherence was predicted by community subjects, not being under a rheumatologist's care, less disease activity, less use of instrumental coping, and higher patient-physician discordance. Intentional non-adherence was predicted by shorter duration under a rheumatologist's care and higher patient-physician discordance. ...
Unintentional non-adherence was predicted by community subjects, not being under a rheumatologist's care, less disease activity, less …
An international cohort study of cancer in systemic lupus erythematosus
Bernatsky S, et al. Arthritis Rheum 2005 - Clinical Trial. PMID 15880596
For all cancers combined, the SIR estimate was 1.15 (95% confidence interval [95% CI] 1.05-1.27), for all hematologic malignancies, it was 2.75 (95% CI 2.13-3.49), and for non-Hodgkin's lymphoma, it was 3.64 (95% CI 2.63-4.93). ...CONCLUSION: These results support the notion of an association between SLE and cancer and more precisely define the risk of non-Hodgkin's lymphoma in SLE. ...
For all cancers combined, the SIR estimate was 1.15 (95% confidence interval [95% CI] 1.05-1.27), for all hematologic malignancies, it was 2 …
328 results
Jump to page
Feedback